Apollo Medical Holdings, Inc. revised earnings guidance for the year ending December 31, 2023. For the year, the company expects revised total revenue to be in the range of $1,340.0 million to $1,390.0 million, net income to be in the range of $59.5 million to $71.5 million and EPS ? diluted to be in the range of $1.10 to $1.20 compared to previously expected total revenue to be in the range of $1,300.0 million to $1,500.0 million, net income to be in the range of $49.5 million to $71.5 million and EPS ?

diluted to be in the range of $0.95 to $1.20.